Overview

Broad strategies for patient-centered research that adapts to a dynamic public health challenge include meaningful patient and community engagement and inclusion in research, sufficient capacity of expertise, effective approaches to reducing stigma and health inequity, collection and analysis of existing data, and embracing innovation from the nation’s small business community. This cross-cutting research is critical to meeting the goals of the Helping to End Addiction Long-term® Initiative, or NIH HEAL Initiative®. 

Open Funding Opportunities

There are no Open Funding Opportunities at this time.

Research Programs

Sharing, integration, and dissemination of HEAL data and findings is a critical goal of the initiative. Research leverages and integrates diverse data streams (such as from health records, mortality records, and pharmacy dispensing databases) and tools to provide the most accurate, real-time assessments of the opioid crisis and its changing dynamics.

This research invests in small businesses developing therapies and technologies to enhance non-opioid pain management as well as to prevent, diagnose, and treat substance use disorders. These efforts can span the entire spectrum of strategies from medications to devices and digital solutions, and include data analysis, information technology, and educational or training materials. 

Stigma occurs at many levels affecting people with opioid use disorder or chronic pain and can prevent people from seeking and receiving treatment. This research is finding solutions to mitigate stigma in its many forms toward improving health and preventing unnecessary deaths from overdose.

The synthesis and real-world application of existing data has the potential to guide and monitor improvements in service delivery to prevent or treat opioid use disorder and pain. HEAL research in the Data2Action program will address gaps in the delivery of evidence-based practices in each of the four pillars of the U.S. Department of Health and Human Services Overdose Prevention Strategy: primary prevention, harm reduction, treatment of opioid use disorder, and recovery support.